PARTNERSHIPS
15 Dec 2025
A licence-and-option agreement in Sweden shows how delivery systems are becoming part of early drug strategy, not a late-stage add-on
INNOVATION
26 Dec 2025
MARKET TRENDS
19 Dec 2025
2 Jun 2026
TECHNOLOGY
27 May 2026
28 Apr 2026
14 Apr 2026
16 Jun 2026
Moderna and Sweden's Nanexa sign a deal worth up to $500M to develop longer-lasting, more stable injectable mRNA therapies
RESEARCH
3 Feb 2025
EMA horizon scanning signals nanotechnology is moving from niche science to a core tool in European drug delivery strategies
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.